Provided by Tiger Trade Technology Pte. Ltd.

Loews

109.83
-0.8700-0.79%
Post-market: 109.830.00000.00%19:30 EDT
Volume:667.48K
Turnover:73.52M
Market Cap:22.45B
PE:13.46
High:111.46
Open:111.46
Low:109.77
Close:110.70
52wk High:121.01
52wk Low:95.10
Shares:204.43M
Float Shares:164.40M
Volume Ratio:1.06
T/O Rate:0.41%
Dividend:0.25
Dividend Rate:0.23%
EPS(TTM):8.16
EPS(LYR):7.97
ROE:9.31%
ROA:1.91%
PB:1.17
PE(LYR):13.78

Loading ...

Loews Corp. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 03

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

GlobeNewswire
·
Jun 30

3 Reasons Loews (L) Looks Close To Fair Value After Its Move To $113.25

Simply Wall St.
·
Jun 27

The lifeline saving regional mums through a computer and their internet connection‘The reality is, 25 per cent of parents are experiencing symptoms and they just don’t know who to reach out to, where to go, what to do.’4 min read

7NEWS
·
Jun 26

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

GlobeNewswire
·
Jun 25

Loews Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Why can’t Britain hold on to prime ministers? It’s the economy

CNN Business
·
Jun 23

Loews (L) Stock After 5-Year 102% Return Is The Current Price Justified

Simply Wall St.
·
Jun 16

Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research

GlobeNewswire
·
Jun 11

Southwest Securities: Post-PD-(L)1 Treatment Resistance Poses Significant Challenge, 2026 to See High Concentration of Catalysts

Stock News
·
Jun 11

Loews Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 11

Loews sets final BDR dividend at BRL 0.22 per share

Reuters
·
Jun 11

MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

GlobeNewswire
·
Jun 10

Token Economy: Redefining the Production Function from Knowledge Acquisition to Real-World Application

Deep News
·
Jun 04

New Trump administration tariffs, this time on forced labor, could come into force as existing ones roll off

Dow Jones
·
Jun 03

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

GlobeNewswire
·
Jun 02

Loews director Dino Robusto acquires $523,700 common shares

Reuters
·
Jun 01

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

GlobeNewswire
·
Jun 01

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma

GlobeNewswire
·
May 31

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

GlobeNewswire
·
May 31